Electrical and Computer Engineering Distinguished Speaker Seminar
The Department of Electrical and Computer Engineering presents Managing Director at PickwickCapital Partners and Adjunct Professor at Brown University and University of Connecticut Mostafa Analoui for our distinguished speaker seminar. This event will take place on Friday, April 7, 2023 in Siegel Hall, room 118 from 2:30–3:30 p.m. This seminar is open to everyone at Illinois Tech. For more information regarding this seminar, please contact the ECE department at 312.567.3400 or ece@iit.edu
Abstract
Upon my arrival in Chicago in August 1986 to pursue my master of science degree at Illinois Tech, I had a clear plan for my life's trajectory. Little did I know that this was only the beginning of a journey that would take me through numerous universities across the United States and around the world. Along the way, I've worked for the largest pharmaceutical company, spearheaded an investment banking division in New York City, founded startups, and much more.
Throughout my experiences, I've had the opportunity to work alongside brilliant innovators, bear witness to significant technical advancements and societal changes, and make my own contributions to the world. While some aspects of this journey were expected, many others took me by surprise. This is the visual story of my life since 1986, and the valuable lessons I've learned along the way—shared for the first time.
Bio
Mostafa Analoui, Ph.D., is managing director at Pickwick Capital Partners and adjunct professor at Brown University and University of Connecticut. Previously, he was the executive director of Venture Development and Technology Incubation Program (TIP) at UConn. Prior to that, he was head of healthcare and life sciences at Livingston Securities in New York City with investment focus in private and public companies in biotech, medtech and healthcare services. He was also the senior director at Pfizer Global Research and Development. Analoui is actively involved in investment, management, and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.
While at Pfizer, he was the site head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Analoui was the director of oral and maxillofacial imaging research, associate professor of radiology at Indiana University, and associate professor of biomedical engineering and electrical and computer engineering at Purdue University. He was also president and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by his post-doctoral fellowship at IBM TJ Watson Research Center in New York.
In addition to industry leadership in biomedical and technology fields, he consults and lectures in the U.S., Europe, and Asia. He has also served on various scientific, regulatory, and business advisory committees and boards, including the NIH, NSF, PhRMA, NASA, and OECD. Analoui has authored over 130 publications, including journal articles, a book, book chapters, and technical reports. Analoui is currently adjunct professor at University of Connecticut (Storrs/Farmington, CT), Brown University (Providence, RI), and Northeastern University (Boston, MA). He is also a senior member of IEEE, SPIE, and RSNA.
He was chairman of the Board of VirtualScopics (NASDAQ: VSCP) and currently serves as chairman of the Board member of Cyclica and Bastion Health.